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ABSTRACT
Haemodialysis is a fast and efficient meth-
od for removing toxins from the body in 
a straightforward manner. This has been 
a regular practice at the Paediatric Clinic 
in Sarajevo, Department of Paediatric In-
tensive Therapy since January 2009. By 
December 2014 there were 34 patients 
treated by haemodialysis, who had un-
dergone 253 haemodialyses in total. There 
were 18 (52.9%) primary nephrologic pa-
tients, while 16 (41.05%) were patients 
whose renal failure was caused by other 
etiology. The main objective of this paper 
is to present the most common conditions 
in childhood that require haemodialysis in 
its treatment. The Department of Paediat-
ric Intensive Therapy for this period had 
hospitalized 1,226 patients in total. Out of 
this number 2.77% of patients required the 
application of haemodialysis in their treat-
ment. 
The results show that the most common 
renal causes to perform haemodialysis 
are: haemolytic uremic syndrome (HUS), 
chronic renal failure, nephrotic syndrome 
and congenital bilateral nephrolithiasis. 
For the others, the most common non-
renal causes are multiple organ dysfunc-
tion syndrome (MODS) that occurs as a 
result of cardiac insufficiency, hepatic in-
sufficiency or after surgeries, as well as in 
hemato-oncologic diseases.
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INTRODUCTION
Haemodialysis is a fast and efficient meth-
od for removing toxins from the body in 
a straightforward manner. It is performed 
extracorporally using dialyzers containing 
an artificial semi-permeable membrane 
that is usually made of cuprophane or cel-
lulose acetate. It requires safe vascular ac-
cess (central venous line) so that the pro-
cess of dialysis can be repeated safely and 
multiple times. (1, 2)
Additional difficulties are the need of an-
ticoagulant therapy (general hepariniza-
tion), as well as the proportionally quick 
and extensive displacement of water and 
dissolved particles that can easily lead to 
hemodynamic stress and disequilibrium. 
The main indications for haemodialysis are 
acute and chronic renal failure, and intoxi-
cation with dialyzable toxins (barbiturates, 
salicylates, methanol). (3) 
It is also used in congestive heart failure, 
severe hypernatremia, metabolic acidosis 
(especially aminoacidemia in newborns), 
hepatic insufficiency, hypercalcemia, and 
primary hyperoxaluria. (4)
Our aim is to present our experiences in 
treating the most common conditions in 
childhood that require haemodialysis in 
their treatment. 
Material and methods. The Department 
of Paediatric Intensive Therapy, Paedi-
atric Clinic of the Clinical Centre of the 
University of Sarajevo, hospitalized 1,226 
patients in the period from January 2009 
till December 2014. Out of this number, 34 
patients (2.77%) required the application 
of haemodialysis in the therapeutic treat-
ment, and 253 haemodialyses were per-
formed in total. 
RESULTS
Kidney disease as a primary reason for 
conducting haemodialysis was diagnosed 
in 18 patients (52.9%); mostly due to acute 
renal failure that had occurred as a result of 
haemolytic uremic syndrome (10 patients 
or 55.55%). 
The second most common cause was 
chronic renal failure that occurred as a re-
sult of late detected congenital anomalies 
in the urogenital tract (vesicoureteral re-
flux, etc.), which was observed in five pa-
tients (27.77%). In two patients the cause 
was congenital nephrotic syndrome and in 
one patient it was bilateral nephrolithiasis 
resulting from abnormal calcium metabo-
lism. 
Other diseases that required haemodialy-
sis in their treatment, but were not a conse-
quence of primary renal impairment, were 
recorded in 16 patients (41.05%). 
In hematooncological patients, two pa-
tients developed sudden liver failure as a 
result of hepatotoxic effects of cytotoxic 
therapy (methotrexate), while in two pa-
tients, after inserting the haemodialysis 
catheter aphaeresis on a cell separator with 
continuous flowhaemodialysis was per-
formed due to the collection of stem cells 
for bone marrow transplantation. 
Five patients developed multiple organ 
failure after various surgeries (correction 
of congenital heart defects, appendectomy, 
polytrauma, etc.) and in these patients the 
treatment required the use of haemodialy-
sis. 
Out of the remaining seven patients, two 
patients developed hardened heart failure 
as the clinical presentation of acute viral 
myocarditis, four patients developed dis-
seminated intravascular coagulation as the 
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clinical presentation of systemic infection 
– sepsis and SIRS, while one patient devel-
oped neonatal metabolic disorder due to 
hyperammoniemia.
According to the gender structure, 16 of 
the patients involved were male and 18 
female. There were 9 patients in the age 
group 0-1 year, 10 in the 1-6 years group 
and 15 in the 7-18 years group. 
The outcome recorded in our patients was: 
8 cured, 15 recovered, and 11 deaths. 
DISCUSSION
At the Department of Paediatric Intensive 
Therapy, Paediatric Clinic of the Clini-
cal Centre of the University of Sarajevo, 
patients with life-threatening conditions 
whose treatment requires haemodialysis 
account for about 3% of overall hospital-
ized patients. 
The leading cause of acute renal failure is 
haemolytic uremic syndrome, which in 
its clinical presentation is dominated by 
microangiopathic hemolytic anemia, ac-
companied by renal dysfunction and hem-
orrhagic diathesis with thrombocytopenia. 
Kidney failure is manifested by oliguria, 
anuria, hyperkalemia and azotemia, which 
among others also requires the application 
of haemodialysis in treatment. (5, 6) 
Congenital nephrotic syndrome includes 
diffuse sclerosis of mesangia (which is a 
rare disease and the mechanism of inherit-
ance is unknown) and the Finnish type of 
nephrotic syndrome (an autosomal reces-
sive disorder caused by mutations in gene 
NPHS1). (7) 
Chronic kidney disease is one of the most 
serious chronic diseases in children. Its 
prevalence in the population aged from 0 
to 18 years is 50-80 children per million. 
It is estimated that the incidence of pro-
gressive renal disease leading to a terminal 
(final) stage of renal failure is 6-8 children 
per million, per year in the population 
under 18 years of age. The most common 
reasons for children to need renal replace-
ment therapy are congenital anomalies of 
the urinary tract and the kidneys. (8, 9) 
Other diseases that require dialysis as an 
integral part of their treatment are the 
life-threatening diseases of different organ 
systems (cardiovascular, hematopoietic, 
immune, etc.) – often with fatal outcomes 
due to the development of multiple organ 
dysfunction, thus requiring a multidisci-
plinary therapeutic approach. (10) 
CONCLUSION
From the analyzed data it can be con-
cluded that about 3% of patients hospital-
ized in the Intensive Therapy Unit for the 
treatment of the underlying diseases re-
quire haemodialysis implementation. The 
most common causes of renal failure are 
hemolytic-uremic syndrome and chron-
ic renal insufficiency due to congenital 
anomalies of urogenital tract. Despite the 
applied measures of treatment, death oc-
curred in 32.35% of patients that required 
haemodialysis, and only partial recovery in 
almost half of the remaining patients was 
observed. 
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